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Abstract: About 2–5% of acute lymphoblastic leukemia (ALL) cases in pediatric patients are infants
with an unfavorable prognosis because of high relapse probability. Early detection of the disease
is, therefore, very important. Despite the fact that leukemia in twins occurs rarely, more attention
has been paid to it in genetic studies. In the present study, through cytogenetic testing, a special
case of concordant ALL in monozygotic twins was presented with different outcomes. In spite
of an acceptable initial consequence to medical treatment in twins, in another brother (Twin B),
early relapse was observed. In the cytogenetic study, both twins expressed t (4; 11) (q21; q23) while
twin A expressed t (2; 7) (p10; q10). No cases have previously reported this mutation. Whether
this translocation has a protective role for leukemia with mixed-lineage leukemia (MLL) gene
rearrangement is still unclear. The difference in the translocation identified in the identical twins is
also subject to further investigations.
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1. Introduction
One of the most common malignancies that could happen between the ages of 2–6 is
ALL. Those under the age of 12 months have an extremely poor prognosis [1–4]. Patients
who go into remission have a high incidence of early relapse [1].
In monozygotic twins, the high rate of concordance of leukemia, early onset of infant
ALL, and observing similar genetic alterations all suggest that infantile leukemia has a
single uterine clonal origin and intra-placental metastasis. MLL-AF4 fusion sequences have
been detected in the Guthrie cards from patients with infantile leukemia [5]. The mixed-
lineage leukemia (MLL) gene that is known as histone-lysine N-methyltransferase 2A
(KMT2A Protein) and is located on chromosome band 11q23, was observed approximately
in about 34–50% of infant acute myeloid leukemia (AML) cases and 50–80% of infant ALL
cases [6]. In older children, the MLL gene rearrangements percentage is 14% and 6% for
AML and ALL cases, respectively [7]. Infants who are negative for MLL rearrangements
have superior outcomes [8]. Based on the studies carried out for investigating concordant
leukemia in monozygotic twins have demonstrated that their cancerous cells of leukemia share
similar clonotypic markers that indicate an origin in one twin in the womb [9,10]. Additionally,
chromosomal translocations are primarily responsible for leukemogenesis events during
the embryonic period that indicates MLL gene fusions in infants with ALL [5,11,12].
2. Case Presentation
In 2015, identical twin brothers were born through cesarean delivery at 38 weeks of
pregnancy. After examining Twin A for assessment and the ecchymosis history at the age of
eight months, it was observed that he had hepatosplenomegaly. The findings of complete
blood count (CBC) were as follows: WBC: 85 × 103/µL with many lymphoblasts, Hb:
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6.5 g/dL, Plt: 43 × 103/µL. As could be seen from Figure 1, the bone marrow aspiration
procedure demonstrated 92% of blasts. Moreover, conducting the immunophenotyp-
ing technique of abnormal cells provided the approval of pro-B-ALL diagnosis that is
CD10-negative in ALL cases without cytoplasmic immunoglobulin (CIg) or surface im-
munoglobulin (sIg). Cytogenetic analysis was positive for t (4; 11) and KMT2A-AFF1
(MLL-AF4) was identified by nested PCR. In accordance with Figure 2, the result of analysis
of human G-banded Karyotype in this study was 46, XY, t (4; 11) (q21; q23)/46 XY idem,
t (2; 7) (p10; q10)/46 XY (Figure 3). The cerebrospinal fluid was normal.
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3. Discussion
In 1882, the first report of similar infant twins with concordant leukemia was described [12].
In 1962, Wollman suggested that the origin of infantile leukemia might start from one twin
and be transmitted to the other through conjoined circulation [13]. Clarkson and Boyes [14]
accepted and developed the hypothesis of metastasis in the placenta. Since the emergence
of that hypothesis, a broad range of monochorionic twins have been reported with in-
fantile leukemia, and the development of in vitro techniques has enabled the molecular
characterization of the disease.
Estimation of the concordance rate for childhood leukemia was first reported in 1964.
In a study by MacMahon and Levy, it is suggested that the concordance rate for acute
leukemia (both ALL and AML) is between 5% and 25% in children at birth [15].
Studies have been demonstrated that, in monozygotic twins with ALL, the concor-
dance rate is high. The mechanism that is introduced in the present study has been
examined in different studies. In spite of that, both twins may be presented with clinical
symptoms of leukemia. These symptoms could not always lead to a precise diagnosis of
disease. In this regard, for making an appropriate decision about any possible risks, at the
initial steps of examination, healthy twins must be detected and be followed up.
By identifying similar gene variations from leukemic cells, the process of identification
of intrauterine monoclonal origin was carried out between infant twin pairs with MLL
gene abnormalities [16]. Translocation of the MLL gene in two groups of patients including
infants and those pediatric patients who were treated previously with topoisomerase II
inhibitors for other cancers [11]. Gu et al. [17] demonstrated that there is a significant
association among the MLL gene and infantile leukemia. In their study, Rubnitz et al. [18]
investigated the presence of MLL gene rearrangements in infant patients with ALL whether
they have t (4; 11) or not and/or other structural chromosomal variations involving 11q23.
They introduced the MLL-AF4 fusion transcript as the most critical prognostic factor in
infant patients with ALL.
So far, the exact number of twins with infant leukemia has not been reported. In 2003,
more than 70 infants were diagnosed with concordant infantile leukemia, who were same-
sex or known monozygotic twin pairs. Concordant leukemia is rare among twins with
different sexes or known dizygotic twin pairs [19].
Previous studies have reported that, in some discordant cases of monozygotic twins
detected with leukemia, MLL gene translocation could be observed. In one case, the placenta
was unknown and, in another one, it was dichorionic. However, in some cases, it was
thought that the placenta initiation will happen postnatally [20,21]. In this regard, the need
to further studies on discordant leukemia in twins seems urgent.
Among twin cases with ALL, the availability of abnormal changes of the chromo-
some provides adequate evidence of the clonal evolution [22]. In a study carried out by
Stumpel et al. [23], the specific pattern of translocation of methylated DNA was identified
among MLL-rearranged infant ALL and then the effect of DNA hypermethylation on the
survival of patients without recurrence was confirmed. The process of identification of
overexpression of B-cell lymphoma 2 as an anti-apoptotic factor was carried out in primary
cells and cell lines with translocation of MLL with t (4; 11) [24]. This has led to development
of molecularly directed therapy.
Kadan-Lottick et al. have conducted a study on the twin’s cancer risks. They inves-
tigated the cancer family history of 211 twins that participated in the Childhood Can-
cer Survivor Study (CCSS). They also calculated proband-wise twin concordance rates.
The achieved results declared that seven pairs of monozygotic twins were concordant to
familial cancer (one of them with non-Hodgkin’s lymphoma (NHL), and six other twins
with leukemia). For all cancers, the concordance rate was 9.5% (20.0% for NHL and 20.7%
leukemia). However, in dizygotic twins, there was no concordance [25]. As a consequence,
through the investigated cases, it was shown that unified cytogenetic characteristics are
integrated with monozygotic twins. Anyway, in the twins, exogenous factors may also be
involved within the leukemia development after in utero initiation.
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Appropriate detection of chromosome translocation and rearranged MLL gene are two
clinical important factors that should be considered for the prognosis and therapy of ALL.
Further studies are required to clarify the mechanism underlying this phenomenon. In the
present study, an infant leukemia sample in a twin with the same cytogenetic characteristic
was investigated. The results were positive for the MLL-AF4 fusion protein with t(4;11)
chromosomal translocation. In spite of early appropriate responses for treatment in both
twins, one of the brothers experienced an early relapse (Twin B), but twin A continued his
complete remission. Two cases of concordant infantile leukemia with discordant outcomes
in twins have been previously reported. The first one was reported by Henning Fedders
et al. in 2014. In their study, it was suggested that twin cells, with relapse, might evade
immune surveillance as a mechanism of disease persistence [26].
Fedders et al. also reported the second case in 2015. Based on their studies, the avail-
ability of high levels of DSC2 expression in residual tumor cells may be a pathogenic
mechanism of the disease in infantile relapsed ALL patients [27].
Finally, we reported third twins with concordant ALL and discordant outcomes. In the
cytogenetic study, twin A expressed t (2; 7) (p10; q10), which was negative in the other
twin. No cases have been reported previously for this mutation. Whether this translocation
has a protective role for leukemia with MLL gene rearrangement still remains unclear.
The difference in the translocation identified in the identical twins is also subject to further
deliberation. Evaluation of more twins with infantile leukemia may contribute toward
identifying new cytogenetic changes.
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